Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

Mostrar otras versiones (1)

BACKGROUND: The National Lung Screening Trial showed that lung cancer (LC) screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC mortality. We evaluated the benefit of prolonged LDCT screening beyond 5 years, and its impact on overall and LC specific mortality at 10 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastorino, U, Silva, M, Sestini, S, Sabia, F, Boeri, M, Cantarutti, A, Sverzellati, N, Sozzi, G, Corrao, G, Marchianò, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637372/
https://www.ncbi.nlm.nih.gov/pubmed/30937431
http://dx.doi.org/10.1093/annonc/mdz117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637372/
https://www.ncbi.nlm.nih.gov/pubmed/30937431
http://dx.doi.org/10.1093/annonc/mdz117

Ejemplares similares